Product Profile of Tablets For Coronary Heart Diseases
Medreich Limited supplies Tablets for Coronary Heart Diseases. Medreich Limited manufactures generic drugs in a wide range of therapeutic areas for applications in pharmaceutical industries. The Tablets for Coronary Heart Diseases is available in the brand name Corstat and is used on patients with a plasma cholesterol level of 5.5 mol/l or greater. The Tablets is effective in hypercholesterolemia and reduces mortality, CHD, non-fatal MI and the need for revascularisation procedures.
Key Features of Tablets For Coronary Heart Diseases
- Very effective in hypercholesterolemia
- Significantly reduces mortality, CHD, non-fatal MI and the need for revascularisation procedures
- Convenient single daily dose
- A marked response is seen within two weeks and the maximum therapeutic response occurs within four to six weeks.
- The response is maintained during continuation of therapy
- Remains stable for 18 hours after reconstitution below 25°C and for 7 days if refrigerated
- Reduce the risk of mortality
- Reduce the risk of coronary death and non-fatal myocardial infarction
- Reduce the risk for undergoing myocardial revascularisation procedures
- Slows the progression of coronary atherosclerosis, including reducing the development of new lesions and new total occlusions.
